Meitav Investment House Ltd. bought a new stake in Lam Research Corporation (NASDAQ:LRCX – Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund bought 25,536 shares of the semiconductor company’s stock, valued at approximately $2,486,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Defined Financial Planning LLC purchased a new stake in shares of Lam Research during the 2nd quarter worth about $225,000. Country Club Bank acquired a new position in Lam Research in the 2nd quarter worth about $247,000. Capital Advisors Inc. OK boosted its position in Lam Research by 0.7% during the second quarter. Capital Advisors Inc. OK now owns 30,134 shares of the semiconductor company’s stock worth $2,933,000 after purchasing an additional 207 shares in the last quarter. Confluence Wealth Services Inc. acquired a new stake in Lam Research in the second quarter valued at approximately $220,000. Finally, Eads & Heald Wealth Management increased its holdings in Lam Research by 3.5% in the 2nd quarter. Eads & Heald Wealth Management now owns 24,128 shares of the semiconductor company’s stock worth $2,349,000 after acquiring an additional 814 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.
Lam Research Stock Performance
Lam Research stock opened at $149.15 on Tuesday. The firm has a 50 day simple moving average of $111.48 and a 200-day simple moving average of $92.99. The stock has a market cap of $188.08 billion, a price-to-earnings ratio of 35.85, a price-to-earnings-growth ratio of 1.78 and a beta of 1.84. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $153.70.
Lam Research Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 24th. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. Lam Research’s dividend payout ratio is 25.00%.
Analyst Ratings Changes
Several equities research analysts have commented on the company. Barclays set a $83.00 price objective on Lam Research and gave the stock an “equal weight” rating in a research note on Monday, July 28th. Rothschild & Co Redburn increased their price objective on Lam Research from $115.00 to $140.00 and gave the company a “buy” rating in a research note on Wednesday, October 1st. Argus raised their price objective on Lam Research from $105.00 to $120.00 and gave the company a “buy” rating in a report on Friday, August 1st. Stifel Nicolaus upped their target price on shares of Lam Research from $92.00 to $110.00 and gave the stock a “buy” rating in a report on Tuesday, July 29th. Finally, Wells Fargo & Company raised their price target on shares of Lam Research from $98.00 to $135.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. Twenty-three analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and an average target price of $119.20.
Read Our Latest Stock Analysis on LRCX
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Articles
- Five stocks we like better than Lam Research
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- Best Stocks Under $5.00
- 3 Exceptional Stocks to Build Long-Term Wealth
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.